Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
From major journals, first or last author from the Institute for Cancer Research
Miihkinen M, Chu Y, Vakkilainen S, Akimov Y, Aittokallio T(2026) Estimating the completeness of large-scale single-cell sequencing projects Nat Commun, 17(1) DOI 10.1038/s41467-026-78221-5, PubMed 42982821
Serguienko A, Sharma J, Shakya R, Cheng Munthe-Kaas M, Boye K, Myklebost O(2026) Pathogenic autoantibodies targeting DNA repair proteins are shared by cancer patients and healthy children later diagnosed with cancer Front Immunol, 17, 1911932 DOI 10.3389/fimmu.2026.1911932, PubMed 42953060
Pinto R, Sjurgard IV, Hauge T, Brandt-Winge S, Pharo H, Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, Kumar T, Øvrebø KK, Rekstad LC, Aahlin EK, Johnson E, Mala T, Lind GE(2026) DNA methylation-based immune profiling reveals distinct subtypes in esophageal adenocarcinoma Eur J Cancer, 249, 117076(in press) DOI 10.1016/j.ejca.2026.117076, PubMed 42950611
Ryan NAJ, Gallon R, McVeigh T, Monahan KJ, Moeslein G, Church DN, Domínguez-Valentin M, Smith T(2026) Lynch syndrome Lancet(in press) DOI 10.1016/S0140-6736(26)01600-4, PubMed 43020098
Lecaudey LA, Ghasemishahrestani Z, Saqagandomabadi V, Wesche J, Ahi EP(2026) Post-transcriptional regulation of FGF signaling: insights from musculoskeletal system J Mol Biol, 170087(in press) DOI 10.1016/j.jmb.2026.170087, PubMed 42976986
Duléry R, Malmberg KJ, Romee R(2026) CAR-NK Cells in B-cell Lymphoma: A New Frontier toward Accessible and Scalable Cellular Therapy Blood Cancer Discov, 7(6), 856-859 DOI 10.1158/2643-3230.BCD-26-0086, PubMed 41996826